Charles River Laboratories International Inc. (CRL)

105.63
1.44 1.34
NYSE : Commercial Services
Prev Close 107.07
Open 107.44
Day Low/High 105.35 / 107.44
52 Wk Low/High 86.25 / 119.05
Volume 324.90K
Avg Volume 374.10K
Exchange NYSE
Shares Outstanding 47.43M
Market Cap 5.13B
EPS 2.60
P/E Ratio 42.14
Div & Yield N.A. (N.A)

Latest News

Charles River Laboratories Announces Executive Management Appointments

Charles River Laboratories Announces Executive Management Appointments

Charles River Laboratories International, Inc. (NYSE: CRL) today announced two new executive management appointments.

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2017 Results From Continuing Operations And Provides 2018 Guidance

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2017 Results From Continuing Operations And Provides 2018 Guidance

Charles River Laboratories International, Inc. (NYSE:CRL) today reported its results for the fourth-quarter and full-year 2017 and provided guidance for 2018.

Charles River Laboratories To Acquire MPI Research

Charles River Laboratories To Acquire MPI Research

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire MPI Research for approximately $800 million in cash, subject to customary closing...

Charles River Laboratories Makes Investments In High-Throughput Screening Infrastructure

Charles River Laboratories Makes Investments In High-Throughput Screening Infrastructure

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca's (NYSE: AZN) high-throughput screening (HTS) and compound management...

Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings And 2018 Guidance Release And Conference Call

Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings And 2018 Guidance Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2017 financial results and provide 2018 guidance on Tuesday, February 13 th, before the market opens.

IIROC Trading Halt - CRL CRL.WT CRL.RT

IIROC Trading Halt - CRL CRL.WT CRL.RT

Charles River Laboratories Adds Jean-Paul Mangeolle To Board Of Directors

Charles River Laboratories Adds Jean-Paul Mangeolle To Board Of Directors

Charles River Laboratories International, Inc. (NYSE:CRL) today announced the appointment of Jean-Paul Mangeolle, former President of AB SCIEX, to its Board of Directors.

Charles River Laboratories Acquires KWS BioTest

Charles River Laboratories Acquires KWS BioTest

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo discovery testing services...

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 36 th Annual J.

Charles River Adds ERS License To CRISPR/Cas9 Service Offering

Charles River Adds ERS License To CRISPR/Cas9 Service Offering

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.

Charles River Announces Success Of Integrated Discovery Project With ENYO Pharma

Charles River Announces Success Of Integrated Discovery Project With ENYO Pharma

Charles River Laboratories International, Inc. (NYSE: CRL) and ENYO Pharma SA today announced the results of a successful collaboration.

GoPro, Alteryx, Charles River Labs, Mallinckrodt: 'Mad Money' Lightning Round

GoPro, Alteryx, Charles River Labs, Mallinckrodt: 'Mad Money' Lightning Round

Jim Cramer spotlights Alteryx, Charles River Labs, Mallinckrodt, and GoPro.

Don't Get Caught on the Wrong Side: Cramer's 'Mad Money' Recap (Wed 11/15/17)

Don't Get Caught on the Wrong Side: Cramer's 'Mad Money' Recap (Wed 11/15/17)

Don't take your cues solely from the action, Jim Cramer says. Big money managers get things wrong all the time, and many stocks are behaving irrationally.

Charles River Laboratories Announces Third-Quarter 2017 Results From Continuing Operations

Charles River Laboratories Announces Third-Quarter 2017 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2017.

Charles River Laboratories Presents Newly Expanded Capabilities At Neuroscience 2017

Charles River Laboratories Presents Newly Expanded Capabilities At Neuroscience 2017

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at...

Https://insphero.com/

Https://insphero.com/

Charles River Laboratories International, Inc. (NYSE: CRL) today announced its partnership with InSphero AG, a leading supplier of 3D solutions for in vitro drug discovery and development.

Charles River Laboratories Changes The Date Of Its Third-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories Changes The Date Of Its Third-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) has changed the date of its third-quarter 2017 earnings release and conference call.

Charles River Laboratories Schedules Third-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories Schedules Third-Quarter 2017 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2017 financial results on Wednesday, November 8 th, before the market opens.

Charles River Research Models In Drug Discovery Award Presented To Sonia Vallabh And Eric Minikel Of The Prion Alliance

Charles River Research Models In Drug Discovery Award Presented To Sonia Vallabh And Eric Minikel Of The Prion Alliance

On Tuesday, September 26, 2017, James Foster, Chairman, President and Chief Executive Officer of Charles River Laboratories International, Inc.

Charles River Laboratories To Present At September Investor Conferences

Charles River Laboratories To Present At September Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including: Wells Fargo 2017 Healthcare Conference in Boston on...

TheStreet Quant Rating: C+ (Hold)